Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: The Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial
- 1 February 2003
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 145 (2), 239-247
- https://doi.org/10.1067/mhj.2003.109
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Specific Impairment of Human Platelet P2Y AC ADP Receptor–Mediated Signaling by the Antiplatelet Drug ClopidogrelArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- CLOPIDOGREL: THE FUTURE CHOICE FOR PREVENTING PLATELET ACTIVATION DURING CORONARY STENTING?Pharmacological Research, 1999
- PFA-100™ System: A New Method for Assessment of Platelet DysfunctionSeminars in Thrombosis and Hemostasis, 1998
- Calpain Regulation of Cytoskeletal Signaling Complexes in Von Willebrand Factor-stimulated PlateletsPublished by Elsevier ,1997
- Localization of the Transmembrane 4 Superfamily (TM4SF) Member PETA-3 (CD151) in Normal Human Tissues: Comparison with CD9, CD63, and α5β1 IntegrinJournal of Histochemistry & Cytochemistry, 1997
- Agonist-activated αvμ3 on Platelets and Lymphocytes Binds to the Matrix Protein OsteopontinJournal of Biological Chemistry, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Platelet activation induced by a murine monoclonal antibody directed against a novel tetra‐span antigenBritish Journal of Haematology, 1995
- Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene SuperfamilyScience, 1990